Clinical Trial: Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Miltefosine (42 Days) for Mucosal Leishmaniasisi
Brief Summary: Miltefosine (longer course) will be used to try to improve the cure rate of mucosal leishmaniasis
Detailed Summary: Miltefosine (42 days) will be used to try to improve upon the cure rate with 28 days of drug for bolivian mucosal leishmaniasisi
Sponsor: AB Foundation
Current Primary Outcome: efficacy
Original Primary Outcome: Same as current
Current Secondary Outcome: safety
Original Secondary Outcome: Same as current
Information By: AB Foundation
Dates:
Date Received: September 7, 2006
Date Started: April 2005
Date Completion: December 2007
Last Updated: May 29, 2010
Last Verified: May 2010